Related Experiment Video
Updated: Mar 12, 2026

Strategies for Assessing Autistic-Like Behaviors in Mice
Published on: September 20, 2024
The DPYSL2 gene connects mTOR and schizophrenia
1McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Abstract:
We previously reported a schizophrenia-associated polymorphic CT di-nucleotide repeat (DNR) at the 5'-untranslated repeat (UTR) of DPYSL2, which responds to mammalian target of Rapamycin (mTOR) signaling with allelic differences in reporter assays. Now using microarray analysis, we show that the DNR alleles interact differentially with specific proteins, including the mTOR-related protein HuD/ELAVL4. We confirm the differential binding to HuD and other known mTOR effectors by electrophoretic mobility shift assays. We edit HEK293 cells by CRISPR/Cas9 to carry the schizophrenia risk variant (13DNR) and observe a significant reduction of the corresponding CRMP2 isoform. These edited cells confirm the response to mTOR inhibitors and show a twofold shortening of the cellular projections. Transcriptome analysis of these modified cells by RNA-seq shows changes in 12.7% of expressed transcripts at a false discovery rate of 0.05. These transcripts are enriched in immunity-related genes, overlap significantly with those modified by the schizophrenia-associated gene, ZNF804A, and have a reverse expression signature from that seen with antipsychotic drugs. Our results support the functional importance of the DPYSL2 DNR and a role for mTOR signaling in schizophrenia.
Insights
The DPYSL2 gene
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- A polymorphic CT di-nucleotide repeat (DNR) in the 5'-untranslated region (UTR) of the DPYSL2 gene is associated with schizophrenia.
- This DNR exhibits allelic differences in response to mammalian target of Rapamycin (mTOR) signaling.
Purpose of the Study:
- To investigate the functional impact of the DPYSL2 DNR and its interaction with mTOR signaling in the context of schizophrenia.
- To explore the downstream molecular effects of the schizophrenia risk variant of the DPYSL2 DNR.
Main Methods:
- Microarray analysis to identify protein interactions with DNR alleles.
- Electrophoretic mobility shift assays to confirm protein binding.
- CRISPR/Cas9 gene editing to introduce the schizophrenia risk variant (13DNR).
- RNA sequencing (RNA-seq) to analyze transcriptome changes in edited cells.
Main Results:
- Differential interaction of DNR alleles with mTOR-related proteins, including HuD/ELAVL4.
- CRISPR/Cas9-edited cells with the 13DNR variant showed reduced CRMP2 isoform levels and twofold shorter cellular projections.
- RNA-seq revealed significant transcriptome alterations in edited cells, enriched in immunity-related genes.
- These gene expression changes showed overlap with ZNF804A targets and reversed signatures of antipsychotic drug treatment.
Conclusions:
- The DPYSL2 DNR is functionally important and plays a role in schizophrenia pathogenesis.
- mTOR signaling is implicated in the molecular mechanisms underlying schizophrenia through its interaction with the DPYSL2 DNR.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Abnormal Proliferation
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...

